Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / FRX Sensulin LLC

FRX Sensulin LLC

HarvestClosed to new capitalFundADV: Venture Capital FundMBX CapitalDelaware
Amounts, each with its basis
Vintage
2016basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$40,000what may be sold, not what was raised; file 021-282601, sworn by the adviser or filed under this vehicle
Form D sold
$40,000as of the filing of Mar 15, 2017, 6 investors
First sale
Jun 30, 2016
Reported GAV
$0on the Form ADV filed Sep 12, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
6
Reported on ADV
Mar 31, 2017 to Sep 12, 2026
Fundraising evidence
Closed to new capital
Form D filed or amended 2017-03-15: the stated $40,000 offering reported fully sold (fr-1)
evidence dated Mar 15, 2017. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Harvest
vintage over 7 years, still reported
age years: 10first sale: 2016-06-30vintage year: $2,016adv gav as of: 2026-09-12vintage basis: form_d_first_saleform d sold usd: $40,000form d offering usd: $40,000form d latest filed at: 2017-03-15
The fund's own reporting through time
6 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 31, 2017Venture Capital Fund$40,000
60%no
Apr 2, 2018Venture Capital Fund$40,000
60%no
Mar 28, 2019Venture Capital Fund$40,000
60%no
Mar 18, 2020Venture Capital Fund$35,000
60%no
Dec 10, 2020Venture Capital Fund$35,000
60%no
Sep 12, 2026Venture Capital Fund$0
6$5,0000%
Principals and agents
4 principals on Form D, 0 placement agents
  • Fundrx Capital Management, LLC Director
  • LLC Assure Fund Management II Director
  • Mateo Johnson Executive Officer
  • Fundrx Capital Management, LLC general partner (ADV 7.B.(1).A.3)
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Mar 31, 2017
    FRX Sensulin LLC first reported on Form ADV by Fundrx Capital Management, LLC (Venture Capital Fund), GAV $40,000
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 15, 2017
    FRX Sensulin LLC filed Form D: $40,000 sold of $40,000, Other Investment Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this vehicle